NCT06039462

Brief Summary

For many children in hospital, having blood tests or cannulation is a significantly distressing event physically, psychologically and emotionally. Use of distraction during invasive procedures is already common practice in paediatrics to improve the experience both for the child and parents. Use of Virtual Reality (VR) and VR Distraction Therapy (VRDT) is a relatively new concept, but has already shown promising results in studies. "VR offers an interactive distraction technique, a contrast to the passive distraction of reading a book or playing games on a tablet … and \[VR\] is thought to alter pain perception and the child's interpretation of pain signals." (Cochrane Library - Virtual reality simulation for reducing pain in children). The project aims to collect data about venepuncture, cannulation, long lines - qualitative and quantitative data - from children and parents. This studyl compares current standard practice with VR distraction therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 23, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

3 months

First QC Date

August 21, 2023

Last Update Submit

September 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in fear and anxiety associated with treatment.

    Questionnaire (x1) completed at the time of intervention

    24 hours

Study Arms (1)

Children undergoing surgery

OTHER
Behavioral: Application of a virtual reality headset

Interventions

Use of a headset to experience a different reality

Children undergoing surgery

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Paediatric patient, aged 8-12 years or 13-18 years.
  • Under care of paediatric department - as inpatient
  • Requiring invasive procedure - including (but not limited to) blood sampling (venepuncture), siting intravenous access (cannulation, long line, Port-a-cath access), lumbar puncture, other device insertion or removal (e.g. catheter, drain, cardiac pacing wires, intra-thecal baclofen pump refills), minor surgical bedside procedures.
  • Consents to study - either child with mental capacity, or parent/legal guardian on behalf of their child.

You may not qualify if:

  • Participants will not be recruited if they or their parent/guardian believe the child will not engage or cannot engage with procedural distraction.
  • Patients not under care of paediatrics (over 18 years of age)
  • If the child has previously been recruited to the study - each child may only be in the study once
  • Contraindications to use of VR or the VR headset
  • Inability to wear headset - facial or skull injury/fracture
  • Marked reduced visual acuity or blindness
  • Interference with care - e.g. requirement of other medical equipment that cannot be worn/administered simultaneously with VR e.g. non-invasive ventilation.
  • Pre-procedure dizziness, nausea, vertigo
  • History of photosensitive epilepsy
  • Potential for poor cooperation with procedure (hence risk of moving) - this is more likely in the age range 8-12 years old. Prior discussion to be held with parents through PIL and consent form to judge if the child is likely to be cooperative.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leeds Teaching Hopsital NHS Trust

Leeds, LS9 7TF, United Kingdom

Location

MeSH Terms

Conditions

Child Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2023

First Posted

September 15, 2023

Study Start

September 23, 2021

Primary Completion

December 13, 2021

Study Completion

December 13, 2021

Last Updated

September 15, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations